Earnings History Data for AxoGen (AXGN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
AxoGen
AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-03-2024 | PM | AXGN | AxoGen | 454.00 | -0.09 | -0.09 | 0.00 | AxoGen Non-GAAP EPS of -$0.06 beats by $0.02, revenue of $42.9M beats by $1.9M [3/5/2024 7:04 AM] |
9.01 | -1.58 (-14.92%) |
9.50 | -1.09 (-10.29%) |
3.45 - 10.83 | 646,170 | 440,000 | 9,950 | ||
| 07-11-2023 | PM | AXGN | AxoGen, Inc. | 173.65 | -0.10 | -0.17 | -0.01 | AxoGen Non-GAAP EPS of $0.01 beats by $0.07, revenue of $41.3M beats by $1.03M [11/7/2023 7:11 AM] |
5.41 | 1.48 (37.66%) |
3.55 | -0.38 (-9.67%) |
3.45 - 13.66 | 777,065 | 480,000 | 4,273 | ||
| 07-08-2023 | AH | AXGN | AxoGen, Inc. | 367.50 | -0.16 | -0.23 | -0.06 | AxoGen Non-GAAP EPS of -$0.03 beats by $0.09, revenue of $38.2M misses by $0.88M [8/7/2023 4:38 PM] |
6.54 | -1.74 (-21.01%) |
8.28 | 0.0 (0.00%) |
5.80 - 13.66 | 3,469,958 | 240,000 | 1,837 | ||
| 09-05-2023 | PM | 7:00 AM ET (May 9) |
AXGN | AxoGen, Inc. | 401.31 | -0.17 | -0.25 | -0.26 | AxoGen GAAP EPS of -$0.10 beats by $0.12, revenue of $36.7M beats by $1.24M [5/9/2023 7:09 AM] |
9.35 | -0.31 (-3.21%) |
0.0 | 0.0 (0.00%) |
7.20 - 13.66 | 236,310 | 200,000 | 0 | |
| 14-03-2023 | PM | 7:00 AM ET (Mar 14) |
AXGN | AxoGen, Inc. | 341.25 | -0.13 | -0.19 | -0.12 | AxoGen Non-GAAP EPS of -$0.03 beats by $0.08, revenue of $36.2M in-line [3/14/2023 7:09 AM] |
8.44 | 0.91 (12.02%) |
6.60 | -0.93 (-12.35%) |
6.87 - 13.66 | 610,578 | 180,000 | 3,044 | |
| 08-11-2022 | PM | 4:00 AM ET (Nov 8) |
AXGN | AxoGen, Inc. | 452.01 | -0.01 | -0.15 | -0.16 | AxoGen reports Q3 earnings beat; narrows FY22 guidance [11/8/2022 7:22 AM] |
12.04 | 1.36 (12.69%) |
10.98 | 0.30 (2.81%) |
6.87 - 14.59 | 247,914 | 170,000 | 504 | |
| 03-08-2022 | AH | 4:05 PM ET (Aug 3) |
AXGN | AxoGen, Inc. | 386.22 | -0.06 | -0.15 | -0.18 | AxoGen Q2 Non-GAAP EPS of -$0.06, revenue of $34.5M, guidance affirmed [8/3/2022 4:31 PM] |
10.49 | 0.03 (0.29%) |
3.92 | -0.40 (-9.26%) |
6.87 - 20.12 | 147,223 | 220,000 | 51,552 | |
| 04-05-2022 | AH | 4:35 PM ET (May 4) |
AXGN | AxoGen | 304.00 | -0.26 | -0.17 | 0.00 | AxoGen Non-GAAP EPS of -$0.20 misses by $0.05, revenue of $31M beats by $0.66M [5/4/2022 5:09 PM] |
9.73 | 1.47 (17.80%) |
8.95 | 0.69 (8.35%) |
6.87 - 23.94 | 1,814,660 | 350,000 | 9,082 | |
|
||||||||||||||||||
| 22-02-2022 | AH | 4:00 PM ET (Feb 22) |
AXGN | AxoGen, Inc. | 310.47 | -0.12 | -0.18 | -0.15 | AxoGen Non-GAAP EPS of -$0.08 beats by $0.05, revenue of $31.53M misses by $0.11M [2/22/2022 4:40 PM] |
7.99 | 0.73 (10.06%) |
7.26 | 0.0 (0.00%) |
6.98 - 23.94 | 831,943 | 320,000 | 1,924 | |
| 03-11-2021 | AH | 4:00 PM ET (Nov 3) |
AXGN | AxoGen, Inc. | 630.06 | -0.16 | -0.19 | -0.04 | AxoGen EPS beats by $0.05, misses on revenue [11/3/2021 4:18 PM] |
13.20 | -2.40 (-15.38%) |
15.00 | -0.60 (-3.85%) |
12.55 - 23.94 | 893,944 | 130,000 | 5,779 | |
|
||||||||||||||||||
| 04-08-2021 | AH | 4:00 PM ET (Aug 4) |
AXGN | AxoGen, Inc. | 835.65 | -0.18 | -0.18 | -0.20 | AxoGen EPS misses by $0.06, beats on revenue [8/4/2021 4:28 PM] |
19.38 | 0.08 (0.41%) |
18.78 | -0.52 (-2.69%) |
10.41 - 23.94 | 221,734 | 90,000 | 1,412 | |
| 05-05-2021 | AH | 4:00 PM ET (May 5) |
AXGN | AxoGen, Inc. | 763.24 | -0.15 | -0.20 | -0.21 | AxoGen EPS beats by $0.07, beats on revenue [5/5/2021 4:28 PM] |
22.08 | 2.44 (12.42%) |
20.05 | 0.41 (2.09%) |
7.65 - 22.89 | 812,070 | 230,000 | 1,029 | |
|
||||||||||||||||||
| 22-02-2021 | AH | 4:00 PM ET (Feb 22) |
AXGN | AxoGen, Inc. | 801.00 | -0.15 | -0.16 | -0.18 | AxoGen EPS beats by $0.03, beats on revenue [2/22/2021 4:30 PM] |
21.21 | 0.02 (0.09%) |
22.25 | 1.06 (5.00%) |
7.16 - 22.89 | 720,948 | 292,668 | 214 | |
| 29-10-2020 | AH | 4:00 PM ET (Oct 29) |
AXGN | AxoGen, Inc. | 502.66 | -0.04 | -0.18 | -0.13 | AxoGen EPS beats by $0.18, beats on revenue [10/29/2020 4:18 PM] |
12.43 | -0.30 (-2.36%) |
13.00 | 0.27 (2.12%) |
7.16 - 18.84 | 463,759 | 244,386 | 550 | |
|
|
||||||||||||||||||
| 05-08-2020 | AH | 4:00 PM ET (Aug 5) |
AXGN | AxoGen, Inc. | 452.09 | -0.20 | -0.33 | -0.16 | AxoGen EPS beats by $0.21, beats on revenue [8/5/2020 4:21 PM] |
12.06 | -0.24 (-1.99%) |
12.70 | 0.39 (3.17%) |
7.16 - 18.84 | 250,865 | 264,674 | 1,700 | |
|
|
||||||||||||||||||
| 06-05-2020 | AH | AXGN | AxoGen, Inc. | 385.86 | -0.21 | -0.20 | -0.21 | 0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | |||
|
|
||||||||||||||||||